<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04110119</url>
  </required_header>
  <id_info>
    <org_study_id>IMUEC441</org_study_id>
    <nct_id>NCT04110119</nct_id>
  </id_info>
  <brief_title>Effectiveness of Chiropractic Application for Acute Low Back Pain</brief_title>
  <official_title>Effectiveness of Chiropractic Application in Patients With Acute Low Back Pain Presenting to the Emergency Department and Receiving Drug Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medipol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medipol University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this project is to investigate the effectiveness of chiropractic application on
      patients who have undergone routine medication as a standard hospital treatment for
      mechanical low-back pain as described in the Clinical Practice Guidelines
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in pain level</measure>
    <time_frame>Up to 5 minutes</time_frame>
    <description>Visual Analogue Pain Scale (VAS) assessment at the fifth minute after the injection of drug. Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. It uses a ten centimeter scale with a minimum of 0 indicating no pain and a maximum of 10 indicating worst pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in pain level</measure>
    <time_frame>Up to 30 minutes</time_frame>
    <description>Visual Analogue Pain Scale (VAS) assessment at the fifth minute after the injection of drug. Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. It uses a ten centimeter scale with a minimum of 0 indicating no pain and a maximum of 10 indicating worst pain.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Low Back Pain, Mechanical</condition>
  <arm_group>
    <arm_group_label>Control: Drug-Only Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with acute lower-back pain who have undergone routine conventional drug treatment at the first visit to the emergency department (75 patients). The drug treatment consists of analgesic-anti-inflammatory (diclophenac sodium 75 mg IM) and myorelaxant (thiocolchicoside 4 mg IM), administered only once.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Case: Drug and Chiropractic Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients, who received chiropractic treatment immediately after the conventional drug treatment as in the control group (75 patients). The chiropractic treatment consists of high speed and low amplitude spinal manipulation techniques, applied only once.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>diclophenac sodium (75 mg, IM) and thiocolchicoside (4 mg, IM)</intervention_name>
    <description>Single intramuscular injection of mixture of two commercial drugs (Analgesic-anti-inflammatory and myorelaxant) at the specified dosages</description>
    <arm_group_label>Case: Drug and Chiropractic Group</arm_group_label>
    <arm_group_label>Control: Drug-Only Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Chiropractic Treatment</intervention_name>
    <description>High speed and low amplitude spinal manipulation techniques are applied to the case group.</description>
    <arm_group_label>Case: Drug and Chiropractic Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged between 19 and 65.

          -  Acute lower-back pain, persisting less than 6 weeks, meeting the diagnostic
             classification of 1 or 2 according to the Quebec Task Force on Spinal Disorders

        Exclusion Criteria:

          -  Previous spine surgery

          -  Spinal nerve root irritation or deficits,

          -  Pregnant women,

          -  Lower-back pain due to occupational accidents

          -  Obesity status (body mass index&gt; 30).

          -  Chronic lower-back pain longer than 6 weeks.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medipol University</name>
      <address>
        <city>Beykoz</city>
        <state>Istanbul</state>
        <zip>34810</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 21, 2019</study_first_submitted>
  <study_first_submitted_qc>September 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2019</study_first_posted>
  <last_update_submitted>September 26, 2019</last_update_submitted>
  <last_update_submitted_qc>September 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medipol University</investigator_affiliation>
    <investigator_full_name>ALI TIMUCIN ATAYOGLU</investigator_full_name>
    <investigator_title>Assistant Prof.</investigator_title>
  </responsible_party>
  <keyword>Mechanical Low Back Pain</keyword>
  <keyword>Chiropractics</keyword>
  <keyword>Analgesic-anti-inflammatory</keyword>
  <keyword>myorelaxant</keyword>
  <keyword>Thiocolchicoside</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

